Related Experiment Video
Updated: Jan 27, 2026

Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells
Published on: June 2, 2022
Glycoengineering of Antibodies for Modulating Functions
Lai-Xi Wang1, Xin Tong1, Chao Li1
1Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland 20742, USA; email: wang518@umd.edu , xtong1@umd.edu , chaoli@umd.edu , johnpgiddens@gmail.com , kevintiezhengli@gmail.com.
Glycoengineering enables precise control over antibody N-glycans, enhancing their therapeutic potential. These advanced techniques allow for the production of homogeneous antibody glycoforms for improved drug efficacy and targeted delivery.
Area of Science:
- Biochemistry
- Immunology
- Glycoscience
Background:
- Antibodies, essential immunoglobulins, are glycoproteins with conserved N-linked oligosaccharides (N-glycans) at the Fc domain.
- Antibody N-glycans significantly influence biological functions and therapeutic effectiveness.
- Heterogeneous antibody glycoforms pose challenges for purification and functional studies.
Purpose of the Study:
- To review major glycoengineering approaches for antibody modification.
- To highlight recent advances in producing defined and site-specifically modified antibodies.
- To focus on glycoengineering for enhanced therapeutic applications, including antibody-drug conjugates.
Main Methods:
- Glycoengineering via manipulation of the glycan biosynthetic pathway.
- In vitro chemoenzymatic glycan remodeling for antibody modification.
- Site-specific antibody-drug conjugation strategies enabled by glycoengineering.
Main Results:
- Glycoengineering facilitates the production of homogeneous antibody glycoforms.
- Site-specific modifications enhance antibody functionality and therapeutic efficacy.
- Advanced glycoengineering methods enable precise control over antibody glycosylation.
Conclusions:
- Glycoengineering is crucial for developing well-defined antibodies with improved therapeutic properties.
- Advances in glycoengineering offer powerful tools for antibody-based drug development.
- Future research will likely focus on further refining these techniques for clinical applications.
Related Concept Videos
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
Functional Groups
Functional Groups
Functionalism
James envisioned psychology's...

